DEF: Diversified Healthcare Trust Announces 2025 Annual Meeting and Proxy Statement
Proxy Statement
Diversified Healthcare Trust will hold its 2025 Annual Meeting of Shareholders virtually on May 29, 2025, to vote on trustee elections, executive compensation, an equity compensation plan, and auditor ratification.
Summary
- Diversified Healthcare Trust (DHC) will hold its 2025 Annual Meeting of Shareholders virtually on May 29, 2025.
- Shareholders of record as of March 13, 2025, are eligible to vote.
- The meeting agenda includes the election of trustees, an advisory vote on executive compensation, approval of the Second Amended and Restated 2012 Equity Compensation Plan, and ratification of Deloitte & Touche LLP as independent auditors.
- Throughout 2024, DHC conducted an analysis of its SHOP assets and operators, reaching 80% SHOP occupancy by year-end, a 70-basis point increase year-over-year.
- SHOP NOI improved by 56%, SHOP revenues increased by 7.3%, and the average monthly rental rate improved by 6.7%, resulting in margin expansion of 250 basis points.
- In the medical office and life science portfolio, 397,000 square feet of leases were executed with an 8.9% average rent rollup, and same-store occupancy remained above 90%.
- In May, DHC closed a $120 million mortgage loan secured by eight medical office and life science properties.
- At year-end, DHC was working to close mortgage loans secured by 27 senior living communities with $340 million in expected loan proceeds.
- In September, DHC announced the sale of 18 triple net leased senior living communities to Brookdale for $135 million, or $154,000 per unit, which closed in February 2025.
- In January 2025, DHC closed on the sale of the Muse Life Science asset in San Diego for $159 million, using the net proceeds to pay down its zero coupon bond.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook with improvements in key metrics, strategic asset sales, and refinancing activities. However, it also acknowledges challenges and risks, resulting in a moderately positive sentiment.
Positives
- SHOP occupancy increased to 80%, the highest since Q1 2020.
- Significant improvements in SHOP NOI, revenues, and rental rates.
- Strong occupancy and lease execution in the medical office and life science portfolio.
- Successful execution of refinancing strategies with mortgage loans and asset sales.
- Proceeds from asset sales are being used to reduce debt.
- The company is actively marketing properties with vacancies and upcoming expirations.
- The company is focused on sustainability and has implemented various environmental initiatives.
- The company has a diverse and experienced board of trustees.
- The company has a strong corporate governance framework.
- The company is committed to shareholder engagement and outreach.
Negatives
- 7.9% of annualized revenue from the medical office and life science portfolio is expiring in 2025, requiring active marketing to mitigate potential vacancy.
- The company relies on RMR for management services and has no employees of its own, creating potential conflicts of interest.
- The company has a complex relationship with RMR and other RMR Clients, which could create potential conflicts of interest.
- The company's sustainability accounting metrics show that a significant portion of its portfolio does not have energy or water consumption data coverage.
Risks
- Upcoming debt maturities in 2025 require strategic refinancing and asset sales.
- Reliance on RMR for management services creates potential conflicts of interest.
- Expiring leases in the medical office and life science portfolio could impact occupancy rates.
- Climate change may lead to the need for capital investments to meet landlord commitments or improve asset resilience.
- Increases in regional water stress may lead to water use restrictions and impact the company's operators and tenants ability to provide services.
- Energy or emissions performance standards may require capital investments to meet standards and offset regulatory fines.
- Maintaining comfort for vulnerable populations may become more costly for SHOP managers.
- Maintaining electrical power during climate disasters is critical.
Future Outlook
DHC plans to use proceeds from mortgage loans, cash, and unencumbered asset sales to address its 2025 debt maturities and is actively marketing properties with vacancies and upcoming expirations.
Management Comments
- Throughout 2024, we conducted a top to bottom analysis of our SHOP assets and operators as we sought to best position our company for further NOI growth.
- We finished the year on a high note by reaching 80% SHOP occupancy for the first time since the first quarter of 2020, which was a 70-basis point increase over the prior year.
- We thank you for your investment in our Company and for the trust you place in us to oversee your interests in our business.
Industry Context
The announcement reflects a focus on optimizing senior housing operations and leveraging medical office/life science assets, aligning with broader industry trends in healthcare REITs.
Comparison to Industry Standards
- The document mentions Brookdale Senior Living as a buyer of DHC's senior living communities, indicating a strategic shift in DHC's portfolio and a consolidation trend in the senior living industry.
- The document references the MSCI U.S. REIT/Health Care REIT Index as a benchmark for peer group total shareholder return, indicating that DHC is aware of its performance relative to its peers.
- The document mentions the EPA's ENERGY STAR program and the U.S. Green Building Council's LEED certification program, indicating that DHC is committed to sustainability and is aligning its practices with industry standards.
Related Party Transactions
- DHC has relationships and historical and continuing transactions with AlerisLife, RMR, RMR Inc., and others related to them, including other RMR Clients, some of which have trustees, directors or officers who are also our Trustees or officers.
- Pursuant to the Master Management Agreement, DHC incurred management fees payable to Five Star of approximately $42.5 million for the year ended December 31, 2024.
- DHC recognized $0.7 million of rent for the year ended December 31, 2024 in connection with lease arrangements with Five Star.
- On February 14, 2025, AlerisLife paid an aggregate cash dividend of $50.0 million to its stockholders, with DHC's pro rata share being $17.0 million.
- Pursuant to DHC's business management agreement with RMR, DHC recognized net business management fees of approximately $16.5 million for the year ended December 31, 2024.
- Pursuant to DHC's property management agreement with RMR, DHC recognized aggregate net property management and construction supervision fees of approximately $7.7 million for the year ended December 31, 2024.
- DHC reimbursed RMR approximately $15.0 million for expenses and costs for the year ended December 31, 2024.
- DHC leases office space to RMR in certain of its properties for RMRs property management offices, recognizing rental income from RMR for leased office space of approximately $0.5 million for the year ended December 31, 2024.
- DHC, RMR Inc. and certain other RMR Clients participate in a combined directors and officers liability insurance policy, with DHC paying a premium of $0.4 million for this coverage for the policy years ending September 30, 2023, 2024 and 2025.
Stakeholder Impact
- Shareholders: The company's performance and strategic decisions directly impact shareholder value.
- Employees of RMR: Compensation and share awards are determined based on the company's performance.
- Tenants: The company's sustainability initiatives and property management practices affect tenant experience.
- Residents of Senior Living Communities: The quality of resident experience is a key focus for the company.
- Communities: The company seeks to strengthen the communities in which it owns properties through its policies and charitable giving.
Next Steps
- Shareholders to vote on proposals at the Annual Meeting on May 29, 2025.
- DHC to continue implementing refinancing strategies to address debt maturities.
- DHC to continue marketing properties with vacancies and upcoming expirations.
- DHC to continue to monitor and manage risks related to climate change and other factors.
Key Dates
| Date | Description |
|---|---|
| March 13, 2025 | Record Date for the 2025 Annual Meeting |
| March 20, 2025 | Date of Proxy Statement and Notice of Annual Meeting |
| May 28, 2025 | Deadline to register in advance to attend the 2025 Annual Meeting |
| May 29, 2025 | 2025 Annual Meeting of Shareholders |
| November 20, 2025 | Deadline to submit shareholder proposals for the 2026 Annual Meeting |
Keywords
Diversified Healthcare Trust, Annual Meeting, Proxy Statement, SHOP, Medical Office, Life Science, RMR, Trustees, Executive Compensation, Equity Compensation Plan, Deloitte & Touche, Sustainability, Real Estate, REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.